MENU
LEGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Legend Biotech (LEGN) Earnings Date & Reports

Legend Biotech Corp is a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

LEGN is expected to report earnings to fall 242.00% to -4 cents per share on November 24

Legend Biotech LEGN Stock Earnings Reports
Q3'25
Est.
$-0.04
Q2'25
Beat
by $0.15
Q1'25
Missed
by $0.06
Q4'24
Beat
by $0.09
Q3'24
Missed
by $0.01
The last earnings report on August 11 showed earnings per share of 2 cents, beating the estimate of -11 cents. With 869.11K shares outstanding, the current market capitalization sits at 6.92B.
View a ticker or compare two or three
LEGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LEGN showed earnings on August 11, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a holding company which engages in the discovery and development of novel cell therapies for oncology and other indications

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2101 Cottontail Lane
Phone
+1 737 317-5050
Employees
1826
Web
https://www.legendbiotech.com